IRIS
DI IOIA, MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.697
EU - Europa 1.655
AS - Asia 1.466
SA - Sud America 158
Continente sconosciuto - Info sul continente non disponibili 122
AF - Africa 20
OC - Oceania 6
Totale 6.124
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.637
SG - Singapore 519
CN - Cina 475
DE - Germania 243
IT - Italia 231
IE - Irlanda 226
UA - Ucraina 182
GB - Regno Unito 169
TR - Turchia 159
SE - Svezia 146
RU - Federazione Russa 142
BR - Brasile 132
VN - Vietnam 129
FI - Finlandia 112
FR - Francia 112
IN - India 68
CA - Canada 43
HK - Hong Kong 20
CZ - Repubblica Ceca 18
BE - Belgio 13
JP - Giappone 12
NL - Olanda 12
PL - Polonia 12
BD - Bangladesh 11
IQ - Iraq 10
CH - Svizzera 9
ZA - Sudafrica 9
MX - Messico 8
PK - Pakistan 8
ES - Italia 7
EU - Europa 7
AR - Argentina 6
AU - Australia 6
ID - Indonesia 6
SA - Arabia Saudita 6
JO - Giordania 5
RS - Serbia 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
IR - Iran 4
KR - Corea 4
MA - Marocco 4
MY - Malesia 4
NP - Nepal 4
PH - Filippine 4
PY - Paraguay 4
VE - Venezuela 4
CO - Colombia 3
JM - Giamaica 3
UZ - Uzbekistan 3
AM - Armenia 2
AT - Austria 2
DK - Danimarca 2
GR - Grecia 2
HR - Croazia 2
IL - Israele 2
KE - Kenya 2
KZ - Kazakistan 2
PE - Perù 2
RO - Romania 2
TN - Tunisia 2
AL - Albania 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
BZ - Belize 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EG - Egitto 1
ET - Etiopia 1
GT - Guatemala 1
HT - Haiti 1
LB - Libano 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
OM - Oman 1
PT - Portogallo 1
SR - Suriname 1
TH - Thailandia 1
TW - Taiwan 1
UY - Uruguay 1
VI - Stati Uniti Isole Vergini 1
Totale 6.009
Salva come PNG Salva come JPEG
Città #
Singapore 384
Chandler 288
San Jose 253
Jacksonville 251
Dublin 223
Ashburn 189
Dallas 169
Beijing 145
Munich 139
Southend 116
Council Bluffs 110
Princeton 94
The Dalles 88
Nanjing 85
Ann Arbor 76
Izmir 73
Chieti 71
New York 64
Dearborn 62
Los Angeles 61
Helsinki 53
Santa Clara 50
Ho Chi Minh City 47
Wilmington 40
Cambridge 39
Altamura 32
Nanchang 29
Moscow 28
Tongling 27
Hanoi 26
Boardman 21
Montreal 19
Hong Kong 18
São Paulo 18
Washington 18
Woodbridge 18
Frankfurt am Main 17
Turku 17
Redondo Beach 16
Grevenbroich 15
Brno 14
Buffalo 14
Kunming 14
Shenyang 13
Brussels 12
Denver 12
Guangzhou 12
Jiaxing 12
London 12
Orem 12
Hebei 11
Norwalk 11
Tianjin 11
Tokyo 11
Toronto 11
Amsterdam 10
Atlanta 9
Brooklyn 9
Hangzhou 9
Houston 9
San Francisco 9
Stockholm 9
Warsaw 9
Baghdad 8
Phoenix 8
San Mateo 8
Changsha 7
Columbus 7
Fermo 7
Monmouth Junction 7
Nuremberg 7
Chennai 6
Dong Ket 6
Falls Church 6
Fribourg 6
Jinan 6
Lanzhou 6
Poplar 6
Amman 5
Belgrade 5
Camerino 5
Manchester 5
Mexico City 5
Mumbai 5
Pescara 5
Roseto Degli Abruzzi 5
Seattle 5
Ankara 4
Boston 4
Changchun 4
Curitiba 4
Da Nang 4
Edinburgh 4
Hanover 4
Johannesburg 4
Montesilvano Marina 4
Olomouc 4
Rome 4
San Vito Chietino 4
Teramo 4
Totale 3.942
Salva come PNG Salva come JPEG
Nome #
Enhanced release of acid sphingomyelinase-enriched exosomes generates a lipidomics signature in CSF of Multiple Sclerosis patients 360
An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis 222
Integrated Lipidomics and Metabolomics Analysis of Tears in Multiple Sclerosis: An Insight into Diagnostic Potential of Lacrimal Fluid 194
Metabolomic Signature in Sera of Multiple Sclerosis Patients during Pregnancy 172
Cleavage of cystatin C is not associated with multiple sclerosis 171
Integration of metabolomics and proteomics in multiple sclerosis: from biomarkers discovery to personalized medicine 168
A lipidomic investigation for the caracterisation of CSF lipid profile in patients with multiple sclerosis 167
Increasing age at disability milestones among MS patients in the MSBase Registry 154
UNRAVELING THE MOLECULAR REPERTOIRE OF TEARS AS A SOURCE OF BIOMARKERS: BEYOND OCULAR DISEASES 152
Acetylcholine in multiple sclerosis: possible involvement in the modulation of the immune response and in oligodendrocyte recruitment. 152
Alemtuzumab treatment of multiple sclerosis in real-world clinical practice: A report from a single Italian center 151
The Multiple Sclerosis Knowledge Questionnaire: a self administered instrument for recently diagnosed patients 149
Development of methods for lipid extraction from CSF and application of mass spectometry techniques for the characterization of the lipid profile and neurosteroids levels in MS patients 146
An information aid for newly diagnosed multiple sclerosis patients improves disease knowledge and satisfaction with care. 143
Contribution of metabolomics to multiple sclerosis diagnosis, prognosis and treatment 143
Metabolomics analysis of cerebrospinal fluid reveals a distintive biochemical alteration associated with multiple sclerosis. 142
Data of safety in a single-center alemtuzumab treated population 141
Convulsive status epilepticus due to new encephalic demyelinating lesions in multiple sclerosis 140
Lipidomic investigations for the characterization of circulating serum lipids in multiple sclerosis 140
A difficult pediatric case: ADEM evolving in multiple sclerosis complicated by progressive multifocal leukoencephalopathy after Natalizumab treatment. 139
Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome. 137
Anti-JCV serostatus, index value and clinical features in patients affected by multiple sclerosis. 135
TLC-MALDI-Imaging approach for lipidomics studies in cerebrospinal fluid reveals low levels of sphingomyelin in multiple sclerosis patients 130
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry. 128
Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis. 127
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy. 125
JCV-Ab serostatus in MS patients treated with Natalizumab 124
OXIDATIVE MODIFICATIONS OF CEREBRAL TRANSTHYRETIN ARE ASSOCIATED WITH MULTIPLE SCLEROSIS 121
Nail loss after teriflunomide treatment: a new potential adverse event 120
Multiphasic Adem or Multiple Sclerosis? Treatement implications. 119
Mass spectrometry based metabonomics of the cerebrospinalfluid highlights a correlation between polar lipids and carnitines levels in multiple sclerosis patients. 118
Natalizumab-associated PML-IRIS: the Chieti experience. 118
Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group 113
Neuropsychological testing and quantitative electroencephalography: a search of neurophysiological markers of cognitive decline in multiple sclerosis 111
Proteomic investigations on differential post-translational modification of transthyretin in multiple sclerosis. 110
Prevalence of JC virus antibodies in human serum and seroconversion rate with first-generation and second generation ELISA: the novel assay improves specificity andsensitivity to detect anti-JC virus antibodies 108
Patient adherence to and tolerability of self-administered interferon beta-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study 101
Relation between Pro-inflammatory Cytokines and Acetylcholine Levels in Relapsing-Remitting Multiple Sclerosis Patients 100
Treatment discontinuation issues in fingolimod treated patients: the Chieti experience. 99
Progressive multifocal leukoencephalopathy associated with natalizumab in paediatric multiple sclerosis 98
Simultaneous early-onset severe autoimmune hemolytic anemia and albuminuria during alemtuzumab treatment for multiple sclerosis 98
Neuropsychological testing and event-related potentials: markers of cognitive impairment in patients with multiple sclerosis 94
Lipidomics analysis reveals low levels of phosphatidylcholines and sphingomyelins in cerebrospinal fluido f multiple sclerosis patients. 83
Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis 82
Spinal cord injury in a patient with multiple sclerosis (MS) with secondary hydromyelia 79
Totale 6.124
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.303
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.303
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022224 0 0 9 42 9 13 10 20 16 9 24 72
2022/2023757 61 109 43 74 93 133 34 54 104 15 24 13
2023/2024394 17 18 33 6 30 181 48 5 1 8 2 45
2024/2025979 50 103 110 11 23 63 94 52 103 44 164 162
2025/20261.841 163 41 234 246 202 92 307 89 186 137 102 42
2026/2027139 31 80 28 0 0 0 0 0 0 0 0 0
Totale 6.124